CAS 168626-94-6: Conivaptan hydrochloride

Description: Conivaptan hydrochloride is a synthetic compound classified as a dual vasopressin receptor antagonist, specifically targeting both V1A and V2 receptors. It is primarily used in the treatment of conditions associated with hyponatremia, particularly in patients with heart failure or syndrome of inappropriate antidiuretic hormone secretion (SIADH). The substance is typically administered intravenously and is known for its ability to promote aquaresis, which is the excretion of free water without the loss of electrolytes. Conivaptan hydrochloride is characterized by its relatively low solubility in water, which can influence its formulation and delivery methods. The compound has a specific molecular structure that contributes to its pharmacological activity, and it is metabolized primarily in the liver, with a half-life that allows for effective dosing regimens. As with any medication, potential side effects may include hypotension, electrolyte imbalances, and infusion site reactions, necessitating careful monitoring during treatment.

Formula: C₃₂H₂₇ClN₄O₂

InChI: InChI=1S/C32H26N4O2.ClH/c1-21-33-28-19-20-36(29-14-8-7-13-27(29)30(28)34-21)32(38)23-15-17-24(18-16-23)35-31(37)26-12-6-5-11-25(26)22-9-3-2-4-10-22;/h2-18H,19-20H2,1H3,(H,33,34)(H,35,37);1H

InChI key: InChIKey=BTYHAFSDANBVMJ-UHFFFAOYSA-N

SMILES: Cl.O=C(NC1=CC=C(C=C1)C(=O)N2C=3C=CC=CC3C=4NC(=NC4CC2)C)C=5C=CC=CC5C=6C=CC=CC6

Synonyms:

• Conivaptan Monohydrochloride
• N-[4-[(4,5-dihydro-2-methylimidazo[4,5-d][1]benzazepin-6(1H)-yl)carbonyl]phenyl]-, monohydrochloride
• N-{4-[(2-Methyl-4,5-dihydroimidazo[4,5-d][1]benzazepin-6(1H)-yl)carbonyl]phenyl}biphenyl-2-carboxamidhydrochlorid
• N-{4-[(2-methyl-4,5-dihydroimidazo[4,5-d][1]benzazepin-6(1H)-yl)carbonyl]phenyl}biphenyl-2-carboxamide hydrochloride
• N-{4-[(2-methyl-4,5-dihydroimidazo[4,5-d][1]benzazepin-6(3H)-yl)carbonyl]phenyl}biphenyl-2-carboxamide hydrochloride (1:1)
• N-{4-[(2-methyl-4,5-dihydroimidazo[4,5-d][1]benzazépin-6(1H)-yl)carbonyl]phenyl}biphenyl-2-carboxamide chlorhydrate
• Vaprisol
• Ym 087
• [1,1'-biphenyl]-2-carboxamide, N-[4-[(4,5-dihydro-2-methylimidazo[4,5-d][1]benzazepin-6(1H)-yl)carbonyl]phenyl]-, monohydrochloride
• [1,1′-Biphenyl]-2-carboxamide, N-[4-[(4,5-dihydro-2-methylimidazo[4,5-d][1]benzazepin-6(1H)-yl)carbonyl]phenyl]-, hydrochloride (1:1)

[1,1'-Biphenyl]-2-carboxamide, N-[4-[(4,5-dihydro-2-methylimidazo[4,5-d][1]benzazepin-6(1H)-yl)carbonyl]phenyl]-, hydrochloride (1:1)

CAS: 168626-94-6

• Formula: C₃₂H₂₇ClN₄O₂
• Purity: 98%
• Color and Shape: Solid
• Molecular weight: 535.0354

Conivaptan hydrochloride

CAS: 168626-94-6

• Purity: 99.9%
• Molecular weight: 535.04g/mol

Conivaptan HCl

CAS: 168626-94-6

• Molecular weight: 535.04g/mol

Conivaptan HCl

CAS: 168626-94-6

• Formula: C₃₂H₂₆N₄O₂·HCl
• Color and Shape: White To Off-White Solid
• Molecular weight: 498.59 36.46

Conivaptan Hydrochloride

CAS: 168626-94-6

• Formula: C₃₂H₂₆N₄O₂·ClH
• Color and Shape: Neat
• Molecular weight: 535.04

Conivaptan hydrochloride

CAS: 168626-94-6

Conivaptan hydrochloride (Vaprisol) is an orally active vasopressin V2 and V1A receptor antagonist, used in …

• Formula: C₃₂H₂₆N₄O₂·HCl
• Purity: 98.33% - 99.86%
• Color and Shape: Solid
• Molecular weight: 535.04

Conivaptan Hydrochloride

CAS: 168626-94-6

Applications Used in treatment of congestive heart failure. References Mao, Z., et al.: Clin. Ther., …

• Formula: C₃₂H₂₆N₄O₂·ClH
• Color and Shape: Neat
• Molecular weight: 535.04

Conivaptan hydrochloride

CAS: 168626-94-6

• Purity: 95.0%
• Color and Shape: Solid
• Molecular weight: 535.0399780273438

Conivaptan hydrochloride

CAS: 168626-94-6

Please enquire for more information about Conivaptan hydrochloride including the price, delivery time and more …

• Formula: C₃₂H₂₇ClN₄O₂
• Purity: Min. 95%
• Color and Shape: White Powder
• Molecular weight: 535.04 g/mol